NeuroSense Therapeutics (NRSN) Interest Coverage Ratio (2021 - 2023)
NeuroSense Therapeutics' (NRSN) quarterly Interest Coverage Ratio came in at 1.15 in Q4 2023, up 70.65% year-over-year from 0.68 in Q4 2022, and down 100.53% quarter-over-quarter from 218.83 in Q3 2023.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Interest Coverage Ratio (2021 - 2023) Analysis & Trends
NeuroSense Therapeutics has disclosed Interest Coverage Ratio across 3 years of filings, most recently posting 1.15 for Q4 2023.
- In Q4 2023, Interest Coverage Ratio rose 70.65% year-over-year to 1.15; the TTM figure through Dec 2023 stood at 26.9 (up 92.61% YoY), while the FY2025 annual figure was 209.15, down 651.95% from the prior year.
- Interest Coverage Ratio came in at 1.15 for Q4 2023 at NeuroSense Therapeutics, down from 218.83 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 331.9 in Q3 2022 to a low of 3.93 in Q4 2022.
- Average Interest Coverage Ratio over 3 years is 88.97, with a median of 9.65 recorded in 2023.
- Year-over-year, Interest Coverage Ratio sank 386.36% in 2022 and soared 70.65% in 2023.
- Over 3 years, Interest Coverage Ratio stood at 0.81 in 2021, then tumbled by 386.36% to 3.93 in 2022, then surged by 70.65% to 1.15 in 2023.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 1.15 in Q4 2023, 218.83 in Q3 2023, and 1.79 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 117.59 |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 493.00 |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -1.15 |
| Sep 30, 2023 | 218.83 |
| Jun 30, 2023 | 1.79 |
| Mar 31, 2023 | 9.65 |
| Dec 31, 2022 | -3.93 |
| Sep 30, 2022 | 331.90 |
| Jun 30, 2022 | 102.57 |
| Mar 31, 2022 | 141.91 |
| Dec 31, 2021 | -0.81 |
API Access
NeuroSense Therapeutics Interest Coverage Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-coverage-ratio", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();